174 related articles for article (PubMed ID: 19702292)
1. Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity.
Wu W; Li R; Bian X; Zhu Z; Ding D; Li X; Jia Z; Jiang X; Hu Y
ACS Nano; 2009 Sep; 3(9):2740-50. PubMed ID: 19702292
[TBL] [Abstract][Full Text] [Related]
2. A practical strategy for constructing nanodrugs using carbon nanotubes as carriers.
Wu W; Jiang X
Methods Mol Biol; 2011; 751():565-82. PubMed ID: 21674355
[TBL] [Abstract][Full Text] [Related]
3. Hydroxycamptothecin Nanorods Prepared by Fluorescently Labeled Oligoethylene Glycols (OEG) Codendrimer: Antitumor Efficacy in Vitro and in Vivo.
Guo Y; Zhao Y; Wang T; Li R; Han M; Dong Z; Zhu C; Wang X
Bioconjug Chem; 2017 Feb; 28(2):390-399. PubMed ID: 27982573
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biological Evaluation of Novel Water-Soluble Poly-(ethylene glycol)-10-hydroxycamptothecin Conjugates.
Guo N; Jiang D; Wang L; You X; Teng YO; Yu P
Molecules; 2015 May; 20(5):9393-404. PubMed ID: 26007190
[TBL] [Abstract][Full Text] [Related]
5. Effect of alkyl chain on cellular uptake and antitumor activity of hydroxycamptothecin nanoparticles based on amphiphilic linear molecules.
Guo Y; Wang T; Zhao S; Qiu H; Han M; Dong Z; Wang X
Eur J Pharm Sci; 2018 Nov; 124():266-272. PubMed ID: 30189259
[TBL] [Abstract][Full Text] [Related]
6. Formulation of injectable glycyrrhizic acid-hydroxycamptothecin micelles as new generation of DNA topoisomerase I inhibitor for enhanced antitumor activity.
Cai J; Luo S; Lv X; Deng Y; Huang H; Zhao B; Zhang Q; Li G
Int J Pharm; 2019 Nov; 571():118693. PubMed ID: 31525442
[TBL] [Abstract][Full Text] [Related]
7. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation of 10-hydroxy camptothecin in supramolecular hydrogel as an injectable drug delivery system.
Li R; Shu C; Wang W; Wang X; Li H; Xu D; Zhong W
J Pharm Sci; 2015 Jul; 104(7):2266-75. PubMed ID: 25980666
[TBL] [Abstract][Full Text] [Related]
9. Hydroxycamptothecin nanoparticles based on poly/oligo (ethylene glycol): Architecture effects of nanocarriers on antitumor efficacy.
Guo Y; Wang T; Qiu H; Han M; Dong Z; Wang X; Wang Y
Eur J Pharm Biopharm; 2019 Jan; 134():178-184. PubMed ID: 30529294
[TBL] [Abstract][Full Text] [Related]
10. Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study.
Sahoo NG; Bao H; Pan Y; Pal M; Kakran M; Cheng HK; Li L; Tan LP
Chem Commun (Camb); 2011 May; 47(18):5235-7. PubMed ID: 21451845
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin.
Li G; Li Y; Tang Y; Zhang Y; Zhang Y; Yin T; Xu H; Cai C; Tang X
Int J Pharm; 2014 Aug; 471(1-2):234-44. PubMed ID: 24861941
[TBL] [Abstract][Full Text] [Related]
12. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
13. A novel multifunctional poly(amidoamine) dendrimeric delivery system with superior encapsulation capacity for targeted delivery of the chemotherapy drug 10-hydroxycamptothecin.
Kong X; Yu K; Yu M; Feng Y; Wang J; Li M; Chen Z; He M; Guo R; Tian R; Li Y; Wu W; Hong Z
Int J Pharm; 2014 Apr; 465(1-2):378-87. PubMed ID: 24530519
[TBL] [Abstract][Full Text] [Related]
14. Amphiphilic Hybrid Dendritic-Linear Molecules as Nanocarriers for Shape-Dependent Antitumor Drug Delivery.
Guo Y; Wang T; Zhao S; Han M; Dong Z; Wang X; Wang Y
Mol Pharm; 2018 Jul; 15(7):2665-2673. PubMed ID: 29782803
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
16. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.
Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X
Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284
[TBL] [Abstract][Full Text] [Related]
17. Increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube.
Sobhani Z; Dinarvand R; Atyabi F; Ghahremani M; Adeli M
Int J Nanomedicine; 2011; 6():705-19. PubMed ID: 21556345
[TBL] [Abstract][Full Text] [Related]
18. Preparation and pharmacodynamics of stearic acid and poly (lactic-co-glycolic acid) grafted chitosan oligosaccharide micelles for 10-hydroxycamptothecin.
Zhou YY; Du YZ; Wang L; Yuan H; Zhou JP; Hu FQ
Int J Pharm; 2010 Jun; 393(1-2):143-51. PubMed ID: 20420886
[TBL] [Abstract][Full Text] [Related]
19. Cyclane-aminol 10-hydroxycamptothecin analogs as novel DNA topoisomerase I inhibitors induce apoptosis selectively in tumor cells.
Zhang S; Geng T; Jiang B; Song G; Ha L; Sun C; Qian Y; Fan Q; Guo H
Anticancer Drugs; 2014 Jul; 25(6):614-23. PubMed ID: 24525588
[TBL] [Abstract][Full Text] [Related]
20. Self-assembling peptide of D-amino acids boosts selectivity and antitumor efficacy of 10-hydroxycamptothecin.
Liu J; Liu J; Chu L; Zhang Y; Xu H; Kong D; Yang Z; Yang C; Ding D
ACS Appl Mater Interfaces; 2014 Apr; 6(8):5558-65. PubMed ID: 24660962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
